Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q35076114

about

Drug treatment of pulmonary hypertension in children Pharmacotherapy for pulmonary hypertension Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia Pulmonary arterial hypertension: a comparison between children and adults Recent progress in understanding pediatric pulmonary hypertension Pulmonary Hypertension in Children.Initial experience with tadalafil in pediatric pulmonary arterial hypertension.Pediatric pulmonary arterial hypertension.Use of inhaled iloprost for the management of postoperative pulmonary hypertension in congenital heart surgery patients: review of a transition protocol.Pulmonary hypertension in infants with bronchopulmonary dysplasia The role of inhaled prostacyclin in treating acute respiratory distress syndrome.Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept Prostacyclin in the intensive care setting.Medical therapy for pediatric pulmonary arterial hypertension Non-congenital heart disease associated pediatric pulmonary arterial hypertension Complete resolution of chronic pericardial effusion with an intensive course of inhaled iloprost in an adult patient with unrepaired ventricular septal defect, and life-threatening severe pulmonary arterial hypertension.Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials Pulmonary hypertension in bronchopulmonary dysplasia Advances in pediatric pulmonary arterial hypertension.Epidemiology and clinical management of pulmonary hypertension in children.Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children.A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost.Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.Role of iNO in the modulation of pulmonary vascular resistance.Review of inhaled iloprost for the control of pulmonary artery hypertension in children Current challenges in pediatric pulmonary hypertension.Advances in therapies for pediatric pulmonary arterial hypertension.Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.Inhaled iloprost for therapy in pulmonary arterial hypertension.Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn.Inhalation therapy to treat pulmonary arterial hypertension.Pulmonary hypertension and breathlessness: is it a combination we can ignore?Current and advancing treatments for pulmonary arterial hypertension in childhood.Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia.

P2860

Q26996078-851FAC18-723C-4B9F-A1C7-229422C02C03 Q27022763-DBDEAC9A-BED9-473B-8103-2700A3896348 Q27025986-79B688EA-3838-44F9-AA2F-56395F269D6F Q27687320-9B2943C7-38B9-417D-B789-253C24488D93 Q27691453-234F677D-A1F6-4096-BADF-7F54E20CBB8D Q30248871-343BA9E3-736A-4C23-AC5F-C3A19E519824 Q33161066-DD1D0915-B967-4118-96A6-12174365B557 Q33163446-D3DF2D4F-8D36-445A-9F6F-A3116426CD95 Q33415586-3B79E34D-75B4-46B6-AC6E-A46016537631 Q34363041-2643BB44-83AC-4BAB-A13B-F17DC13884C6 Q34490411-29A47FBA-5971-46A8-91C4-E3D6025FCA4B Q34890485-D8D543A9-A021-4EBC-BD52-8F490CB37C12 Q35050464-A421C6B4-2CC3-4E55-9121-8075B013D7B4 Q35079604-03F56B33-4F11-40DC-A17E-D9727A58037B Q35165691-305381A9-4076-462A-A9AF-9CC923A165F1 Q35183562-5729E78B-9C43-4E12-856D-313553FBD723 Q35552825-72378852-59A7-4294-ACC7-40C66F822CE4 Q35731631-0FFFD161-D8CE-4DE3-B242-69A5C00936B8 Q35869437-7748C187-73AF-4773-9C61-9165DAD4F260 Q36223055-B2F09D63-531D-4C24-9D73-9CAA14C01D1B Q36427718-CB732AAB-14BB-4571-A212-70A6789F0EA3 Q36481525-039F585D-CCA6-4765-86BC-7F452D8F051A Q36718346-248B52EE-0421-4386-AB54-D80EE2E461E2 Q36763080-B4226728-A883-4BA8-908A-187926A43592 Q36777766-D435FAF5-9175-4BA7-A5C1-82C8D7C9D473 Q37133820-4E5E8200-B5C1-4DEA-BE07-EEFEF1649376 Q37139801-7C681642-C1FE-4940-9A74-7EDAF7E93493 Q37308066-633DB921-AC35-494A-A764-EDB629B69629 Q37341687-99E81452-D5D8-4BCA-8948-3AB7BFC8AAD4 Q37479077-D4D429F0-71EB-480B-9C85-A70B239F371A Q37540613-33667F4A-420D-4989-A98C-9A45FD75516F Q37755020-C0C14ED0-49FF-47B4-9353-8853436AF898 Q37858415-C8787F59-6350-4F23-94CC-B5D29409AF96 Q37867662-E8F44BD8-891B-42B1-94A5-0369424944B6 Q37879213-4FA4CBB1-26DE-4B56-974B-65AB5E92BE57 Q38116853-7319CD02-2E89-4035-8913-00EAC983793F Q38162947-0328F473-A9A8-4DCF-B6E9-3EE05A46562F Q38175197-395E6641-DF51-4D1D-B40A-1EF11DE26F40 Q38232339-5EED476B-C891-4013-A690-90BBEE6F7608 Q38271628-38F65CCF-0211-4456-93F3-B6B8C4C96D10

P2860

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q35076114

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Short- and long-term effects o ...... lmonary arterial hypertension.

@ast

Short- and long-term effects o ...... lmonary arterial hypertension.

@en

type

label

Short- and long-term effects o ...... lmonary arterial hypertension.

@ast

Short- and long-term effects o ...... lmonary arterial hypertension.

@en

prefLabel

Short- and long-term effects o ...... lmonary arterial hypertension.

@ast

Short- and long-term effects o ...... lmonary arterial hypertension.

@en

P1433

Q35076114-EBB0EA51-C63E-4FE6-B7D0-BBB48CF897D2

P1476

Q35076114-A60532CB-F79C-48F6-BDA6-487DDFFE0601

P2093

Q35076114-021115D9-F7FA-4BE3-9356-2B062D4CB907

Q35076114-05330106-EFDA-4D3B-B286-64B1D3C7477D

Q35076114-234B1739-5723-4299-8C8D-C1FC30F2DAF3

Q35076114-258A2120-9074-46B1-9E25-3185704C5836

Q35076114-2A6D1BEF-8190-442B-BCCC-D08CE4F61B63

Q35076114-319B0627-BCBE-4EE9-8D09-4A3E098A2F37

Q35076114-A49C0F4F-8F7A-4FD3-83C0-489CC321FFB9

Q35076114-BC80AE59-B2E1-4213-90D8-6F12AE878D63

Q35076114-C92DF26E-2ACB-4068-BE89-8463C8776091

Q35076114-DCA84670-421E-4BB9-A5EA-B19DE974B9E1

P2860

Q35076114-23F6BF2F-1522-4F14-86F8-F04BCD59FCFF

Q35076114-26FC01F7-9FE6-47E9-9D75-A7B4112F2956

Q35076114-2EBB2CEB-BE10-4DDC-A4F3-9062BDAD9220

Q35076114-3062EF18-020B-4412-B9DF-1E46374E8C44

Q35076114-3BE4B225-8A7D-4F9B-A4B7-2D091EA88482

Q35076114-3E724DDA-E396-4D2A-9DA9-092CDB8F69C0

Q35076114-40B58EFA-B08E-4A76-AA8F-152F0CE6262A

Q35076114-4367F25B-E478-4406-9668-08E94FCAD83A

Q35076114-4498C934-30DA-4F39-A9E4-567B2FD5533A

Q35076114-54F514DA-F45D-4DBD-9C36-8E1C478EF9C8

P304

Q35076114-FD95E49E-C1A9-4DE1-904B-5FC94E9FAEE8

P31

Q35076114-307DC7EF-13C6-464E-A70B-C422AEC5D7E7

P356

Q35076114-373EAB99-0F87-460E-BB3C-60BAF869A21A

P407

Q35076114-F50F83BE-06B8-46F2-B6F8-287A6FBB777D

P433

Q35076114-1C6E77B0-52C8-4E6A-8DE8-C41D60206C43

P478

Q35076114-55C48E02-5C43-430C-BF00-2EF855B951CB

P577

Q35076114-2D7C5A8B-C9FA-4856-9A25-002C20E55B5C

P5875

Q35076114-71B2F6D1-2238-4B7E-A15F-F2DF96C19C8D

P698

Q35076114-0E5E1103-9CFD-4CE8-99F6-46AD5731CA2C

P932

Q35076114-0E83442D-410D-40FE-89CD-FEDFDCA681DC

P356

J.JACC.2007.09.031

P1433

Journal of the American College of Cardiology

P1476

Short- and long-term effects o ...... lmonary arterial hypertension.

@en

P2093

Aimee K Doran

http://www.w3.org/2001/XMLSchema#string

D Dunbar Ivy

http://www.w3.org/2001/XMLSchema#string

Daniela Brady

http://www.w3.org/2001/XMLSchema#string

Donna Parker

http://www.w3.org/2001/XMLSchema#string

George B Mallory

http://www.w3.org/2001/XMLSchema#string

Kelly J Smith

http://www.w3.org/2001/XMLSchema#string

Lori Claussen

http://www.w3.org/2001/XMLSchema#string

Maurice Beghetti

http://www.w3.org/2001/XMLSchema#string

Robyn J Barst

http://www.w3.org/2001/XMLSchema#string

Steven H Abman

http://www.w3.org/2001/XMLSchema#string

P2860

Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Inhaled iloprost for severe pulmonary hypertension.

Diagnosis and differential assessment of pulmonary arterial hypertension.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

Response to bosentan in children with pulmonary hypertension.

Treatment of pulmonary arterial hypertension.

P304

161-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2007.09.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5659311

http://www.w3.org/2001/XMLSchema#string

P698

18191742

http://www.w3.org/2001/XMLSchema#string

P932

3125969

http://www.w3.org/2001/XMLSchema#string